Capecitabine plus paclitaxel as front-line combination therapy for metastatic breast cancer: a multicenter phase II study. [electronic resource]
Producer: 20040629Description: 2321-7 p. digitalISSN:- 0732-183X
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Breast Neoplasms -- drug therapy
- Capecitabine
- Deoxycytidine -- administration & dosage
- Disease Progression
- Female
- Fluorouracil -- analogs & derivatives
- Humans
- Middle Aged
- Neoplasm Recurrence, Local
- Paclitaxel -- administration & dosage
- Survival Analysis
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.